A lower incidence rate of hypoglycemia was observed in the sitagliptin group compared with the non-exposed group [ 7.0 vs. 14.3 per 100 patient-years ; difference -7.6 ( 95 % CI -11.2 to -4.3 ] ) , primarily due to greater use of sulfonylureas in the non-exposed group .